Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956. 

Biotechnology

Life Sciences

Pharmaceutical

Regis Technologies

Tadgh Prendeville

Richard Myer

Steven Leyvi

Othman Tyane

Julius Jackson

James Colegrove

Charvi Payghode

Sophia Imeroni

Samantha Wijeweera

Katie Kretschmer

Adam Fox

Simeon Pickett

Judy Koppe

James Letzkus

Alyson Battis

Lakulish Patel

Alan Henderson

Melissa Wilcox

Burrous Martin

Burr Martin

The Leadership Team at Regis Technologies sets the strategic direction for the company, oversees business development initiatives, ensures financial and operational efficiency, and fosters a culture of innovation and compliance. They collaborate closely to drive growth, maintain high standards of quality, and guide the organization's mission to support pharmaceutical and biotechnology partners in advancing drug candidates to market.

Leadership Team

Chemistry and Research Team

Operations

Quality Assurance and Control Team

Leadership Team

About

Team members

Other teams at Regis Technologies

Chemistry and Research Team

Operations

Quality Assurance and Control Team